Free Trial

Andre Jerome Sells 13,390 Shares of Aurora Cannabis Inc. (TSE:ACB) Stock

Aurora Cannabis logo with Medical background

Aurora Cannabis Inc. (TSE:ACB - Get Free Report) Senior Officer Andre Jerome sold 13,390 shares of the firm's stock in a transaction that occurred on Wednesday, February 12th. The shares were sold at an average price of C$9.30, for a total transaction of C$124,524.32.

Aurora Cannabis Stock Performance

Shares of TSE:ACB traded up C$0.04 during trading on Friday, reaching C$8.34. The stock had a trading volume of 841,226 shares, compared to its average volume of 665,078. The company has a quick ratio of 2.48, a current ratio of 3.42 and a debt-to-equity ratio of 18.72. The stock has a fifty day simple moving average of C$6.65 and a two-hundred day simple moving average of C$7.22. The firm has a market capitalization of C$456.27 million, a price-to-earnings ratio of -10.30 and a beta of 2.71. Aurora Cannabis Inc. has a 52 week low of C$3.84 and a 52 week high of C$12.85.

Wall Street Analyst Weigh In

Several brokerages have recently weighed in on ACB. Atb Cap Markets upgraded Aurora Cannabis from a "hold" rating to a "strong-buy" rating in a report on Wednesday, February 5th. ATB Capital cut their price target on shares of Aurora Cannabis from C$11.00 to C$8.50 in a report on Tuesday, December 17th. Finally, TD Securities raised shares of Aurora Cannabis to a "strong-buy" rating in a research note on Thursday, December 12th. Three investment analysts have rated the stock with a hold rating and two have given a strong buy rating to the company's stock. According to data from MarketBeat.com, Aurora Cannabis currently has a consensus rating of "Moderate Buy" and an average target price of C$7.11.

Check Out Our Latest Stock Report on ACB

About Aurora Cannabis

(Get Free Report)

Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Aurora, CanniMed, Daily Special, MedReleaf, and San Rafael '71. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements or cultivation facilities in more than 20 countries.

Featured Articles

Should You Invest $1,000 in Aurora Cannabis Right Now?

Before you consider Aurora Cannabis, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aurora Cannabis wasn't on the list.

While Aurora Cannabis currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Magnificent 7 Stocks Shift Toward Stability and Selective Growth
4 Biotech Stocks on the Verge of Massive Breakthroughs
New AI Deals Just Sent These 4 Infrastructure Stocks Soaring

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines